Covid-19 vaccines and hearing loss and tinnitus (NEW 5/6, Website, News)World Health Organization (WHO) - Pharmaceuticals Newsletter
29 April 2022
Rausch, C, et al
(No. 1, 2022) page 18
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink (Website, Publication)JAMA Network
26 April 2022
Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink. JAMA Netw Open. 2022;5(4):e228879. doi:10.1001/jamanetworkopen.2022.8879
Hanson KE, Goddard K, Lewis N, et al.
Surveillance data from the Vaccine Safety Datalink showed increased incidence rate of confirmed GBS 1 to 21 days after receiving the Ad.26.COV2.S (Janssen).
Do I qualify for a COVID-19 vaccine booster and which one? (Website, Regulatory)FDA
Use this chart to find out if you’re eligible for a COVID-19 vaccine booster and which one.
Coronavirus (COVID-19) Update: FDA Authorizes Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals (Website, Regulatory)FDA
29 March 2022
The FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals.